Upload
osborn-hoover
View
216
Download
1
Tags:
Embed Size (px)
Citation preview
Papillary Microcarcinoma of the Thyroid
T.T. Law Queen Mary Hospital
Joint Hospital Surgical Grand Round16th January, 2010
112/04/18 Free template from www.brainybetty.com 2
Background
• Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
• Papillary thyroid microcarcinoma (PTMC) represents a particular variant of papillary thyroid carcinoma.
112/04/18 Free template from www.brainybetty.com 3
Definitions
World Health Organization (WHO) definition of PTMC:
– Papillary carcinomas of the thyroid with maximal diameter of ≤1.0cm
Hedinger C et al. WHO international histologcial Classification of tumors, vol 11.
112/04/18 Free template from www.brainybetty.com 4
Incidence
• Wide range of prevalence: ranging from 3 -36% in autopsies studies – Number of sectioning levels – Histologic criteria for diagnosis – Possible population/geographical
variation
Harach HR et al. Cancer 1985;56:531-8
112/04/18 Free template from www.brainybetty.com 5
Incidence
• Increase in incidence in recent years• 30-40% of patients had PTMC among all
patients with PTC • 2-24% of patients after thyroidectomy for
presumbly benign thyroid disease• Increase use of ultrasound (USG) and USG-
guided fine-needle aspiration (FNA)
Bramley MD, et al. Br J Surg 1996;83:1674-83
Fink A, et al. Mod Pathol 1996;9:816-20
112/04/18 Free template from www.brainybetty.com 6
USG Features
• Hypoechoic or heterogenous
• Microcalcifications within lesion
• Irregular margins• Taller than wider dimension• Intranodular vascularity
Hubbard GH et al. Endocrine Surgery. Springer 2009
Transverse (A) and longitudinal (B) thyroid USG images of a suspicious thyroid nodule
(A)
(B)
112/04/18 Free template from www.brainybetty.com 7
Management
• Controversies in the management: 1. Total/near-total thyroidectomy versus
lobectomy
2. Need for neck dissection
3. Need for radioiodine (RAI)
112/04/18 Free template from www.brainybetty.com 8
Clinical Scenarios
1. Pre-operative diagnosis of PTMC suspected or confirmed (overt PTMC)
– US – Fine-needle aspiration of suspicious thyroid
nodules or lymph nodes (LN)
2. Incidental finding of PTMC in thyroidectomy specimen for presumbly benign disease (occult PTMC)
112/04/18 Free template from www.brainybetty.com 9
Overt PTMC
• Total or near-total thyroidectomy than lobectomy is preferred – High incidence of multifocal disease – Avoids risk of reoperation – Possibility of better monitoring post-op by
scintigraphic scan and thyroglobulin measurements
Sakorafas GH et al. Cancer Treat Rev 2005;31:423-38
112/04/18 Free template from www.brainybetty.com 10
Overt PTMC - Neck
• Routine central neck dissection (CND) or selective approach?
• Pre-operative confirmed lymph node metastases -> therapeutic central neck dissection
• Pre-operative no lymph node metastases + intra-operative no suspicious lymph nodes ->
? Prophylactic neck dissection
112/04/18 Free template from www.brainybetty.com 11
Anatomy of Cervical LN
112/04/18 Free template from www.brainybetty.com 12
Overt PTMC – Central Neck Dissection
Proponents Opponents •High incidence of LN metastases in PTMC noted after prophylactic neck dissection
•Increased risk of injuring the recurrent laryngeal nerve and parathyroid glands
•CND provides pathologic information on nodal metastases, which may assist the post-op RAI planning
•Central node metastases unrelated to disease-free survivalIto Y et al. World J Surg 2006;30:91-9
•No need for wound extension •Low incidence of central compartment recurrence in patients without LN dissection
•RAI decreased LN recurrence rate from 7% to 0% in patients with negative LN on presentation and no neck dissectionChow SM et al. Cancer 2003;98:31-40
112/04/18 Free template from www.brainybetty.com 13
Overt PTMC - RAI
• Is the use of RAI after total thyroidectomy associated with lower rate of recurrence in PTMC?
• Japan: restricted use of RAI, Japanese surgeons support prophylactic neck dissection
Ito Y et al. World J Surg 2008;32:729-39
112/04/18 Free template from www.brainybetty.com 14
Overt PTMC - RAI
• RAI may reduce recurrence rate in high risk patient, yet it remains a controversial issue
• Unfavorable prognostic factors: – Older age (>45 years)– Distant metastases– Capsular invasion, vascular invasion – Lymph node metastases – Uncapsulated tumor – Multifocality – Non-incidental cancer
Sakorafas GH Cancer Treat Rev. 2005;31:423-38
112/04/18 Free template from www.brainybetty.com 15
Overt PTMC - RAI
• RAI may reduce nodal recurrence in patients who were negative for lymph node metastasis at presentation and who were not treated with neck dissection2
• Speculation: RAI may eradicate microscopic metastases in LNs, yet the clinical significance of these micrometastases is difficult to predict
• RAI is indicated for patients with distant metastases
Chow SM et al. Cancer 2003;98:31-40
112/04/18 Free template from www.brainybetty.com 16
Occult PTMC
• Excellent prognosis• Patients died of other diseases than of occult PTMC
Lo CY et al. World J Surg 2006;30:759-66
112/04/18 Free template from www.brainybetty.com 17
Occult PTMC
• A benign disease?• Is completion thyroidectomy indicated if
PTMC is incidentally discovered following a limited thyroid surgery?
• Controversial topic
112/04/18 Free template from www.brainybetty.com 18
Occult PTMC
• Very low incidence of lymph node metastases or tumor recurrence in clinically occult PTMC treated with thyroidectomy alone
• Neck dissection and RAI generally not indicated
Lo CY et al. World J Surg 2006;30:759-66
Besic N et al. Ann Surg Oncol 2009;16:920-8
112/04/18 Free template from www.brainybetty.com 19
PTMC – Suppression therapy
• Is suppressive T4 treatment necessary for patients with PTMC (especially for those with hemithyroidectomy)?
• Recommended by some authors1 but other2 showed that patients who discontinued TSH suppression within a few years did not had significantly higher incidence of recurrence
1Bramley MD et al. Br J Surg 1996;83:1674-83
2Noguchi S et al. World J Surg 2008;32:747-53
112/04/18 Free template from www.brainybetty.com 20
Follow up
• Clinical exam • Neck USG • Measurements of thyroglobulin (Tg) serum
levels • Long term surveillance is necessary as
recurrence may occur after many years
112/04/18 Free template from www.brainybetty.com 21
Social/Psychological Impact
• Should we mention the diagnosis of “carcinoma” to patients who have a completely excised PTMC?
• Important to discuss with patient about the nature of the disease, its high curability rate and excellent prognosis
112/04/18 Free template from www.brainybetty.com 22
Conclusion
• Incidence of PTMC is increasing due to use of USG and USG-guided FNA for small thyroid lesions
• Prognosis is excellent for the majority of patients with PTMC
• Optimal treatment is important to decrease risk of lymph node recurrence and distant metastases in clinically overt PTMC
• Optimal treatment for occult PTMC is debatable
112/04/18 Free template from www.brainybetty.com 23
112/04/18 Free template from www.brainybetty.com 24
PTMC – Endoscopic thyroidectomy
• Several retrospective studies of endoscopic thyroidectomy for PTMC
• 499 patients with PTMC were enrolled between 2005-2007• 275 patients underwent gasless endoscopic thyroidectomy
via the axillary route (endo group)• 224 patients underwent conventional open thyroidectomy
(open group) • Statistically significant longer operating time in endo group
(138.5 +/- 49.0 min vs. 105.5 +/- 41.6 min; P < 0.0001)• Smaller number of lymph nodes were retrieved in the endo
group compared to the open group (5.05 +/- 2.94 vs. 5.96 +/- 4.50, P = 0.007)
• Short term oncological results were comparable between 2 groups
Jeong JJ et al. J Surg Oncol 2009 Nov(1) 100(6)477-80
112/04/18 Free template from www.brainybetty.com 25
Occult PTMC - Observation
• Is observation and non-operative management feasible in occult PTMC?
• Japanese study: 162 patients with PTMC treated with observation alone
• Mean follow up: 46.5 months • >70% tumors no change in size, 10.2% increase
in size by >10mm, 1.2% lymph node metastases in lateral compartment
• Surgical treatment only when tumor is progressing -> not late according to investigators
Ito Y et al. Thyroid 2003;13:381-7